Brown, Lisle/Cummings’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.62M | Sell |
33,085
-2,330
| -7% | -$184K | 0.7% | 40 |
|
|
2025
Q1 | $3.18M | Buy |
35,415
+1,233
| +4% | +$111K | 0.92% | 28 |
|
|
2024
Q4 | $3.4M | Buy |
34,182
+1,995
| +6% | +$198K | 1.01% | 24 |
|
|
2024
Q3 | $3.66M | Buy |
32,187
+1,250
| +4% | +$142K | 1.11% | 23 |
|
|
2024
Q2 | $3.83M | Buy |
30,937
+2,074
| +7% | +$257K | 1.25% | 19 |
|
|
2024
Q1 | $3.81M | Sell |
28,863
-25
| -0.1% | -$3.3K | 1.29% | 20 |
|
|
2023
Q4 | $3.15M | Buy |
28,888
+8,974
| +45% | +$978K | 1.17% | 22 |
|
|
2023
Q3 | $2.05M | Buy |
19,914
+419
| +2% | +$43.1K | 0.93% | 26 |
|
|
2023
Q2 | $2.25M | Buy |
19,495
+2,895
| +17% | +$334K | 1.01% | 23 |
|
|
2023
Q1 | $1.77M | Sell |
16,600
-960
| -5% | -$102K | 0.9% | 27 |
|
|
2022
Q4 | $1.95M | Buy |
17,560
+548
| +3% | +$60.8K | 1.05% | 25 |
|
|
2022
Q3 | $1.47M | Buy |
17,012
+100
| +0.6% | +$8.61K | 0.86% | 32 |
|
|
2022
Q2 | $1.54M | Sell |
16,912
-657
| -4% | -$59.9K | 0.85% | 32 |
|
|
2022
Q1 | $1.44M | Buy |
17,569
+320
| +2% | +$26.3K | 0.69% | 39 |
|
|
2021
Q4 | $1.32M | Buy |
+17,249
| New | +$1.32M | 0.66% | 41 |
|